Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Mantle-Cell 1Lymphoma 1Leukemia 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 12Vincristine 10Doxorubicin 10Etoposide 8Rituximab 6Prednisone 6Cytarabine 6Dexamethasone 5Bleomycin 5Zidovudine 4Methotrexate 4Leucovorin 4Filgrastim 4Peripheral Blood Stem Cell Transplantation 3sargramostim 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vinblastine 2Polymerase Chain Reaction 2Melphalan 2Dacarbazine 2Carmustine 2Antiretroviral Therapy, Highly Active 2Allopurinol 2prednylidene 1pembrolizumab 1liposomal doxorubicin 1ibrutinib 1efavirenz 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Transplantation Conditioning × Lymphoid × Clear all
NCT02378922 2018-12-27

Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Fred Hutchinson Cancer Center

Phase 1 Withdrawn
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡